Publications

Any
    Any

      5596 Results

      Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

      Authors
      N Kuderer;TBD Other
      Journal / Conference
      Lancet Jun 20;395(10241):1907-1918
      Year
      2020
      Research Committee(s)
      Cancer Care Delivery and Multiple sites
      PMID
      PMID32473681
      PMC
      PMC7255743

      What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report

      Authors
      M Bertagnolli;C Blanke;W Curran;D Hawkins;R Mannel;P O'Dwyer;M Schnall;N Wolmark
      Journal / Conference
      Cancer Dec 1;126(23):5022-5029
      Year
      2020
      Research Committee(s)
      Multiple sites
      PMID
      PMID32970346
      PMC
      PMC7667615

      Evaluating Serum Thymidine Kinase 1 (TK1) as a Prognostic and Predictive Marker in Estrogen Receptor (ER) Positive Metastatic Breast Cancer (MBC) Patients Receiving First Line Endocrine Therapy in the SWOG S0226 Trial

      Authors
      C Paoletti;W Barlow;M Bergqvist;R Mehta;J Gralow;G Hortobagyi;K Albain;L Pusztai;P Sharma;A Godwin;A Thompson;D Hayes;J Rae
      Journal / Conference
      San Antonio Breast Cancer Symposium (December 8-12, 2020, San Antonio TX), poster presentation, abst. PS2-04
      Year
      2020
      Research Committee(s)
      Breast
      Study Number(s)
      S0226

      Dual Classification by Immune Response Signature and Homologous Recombination Deficiency Reveals Immune-Dependent and -Independent Prognostic Groups in patients with Triple Negative Breast Cancer (TNBC) treated with AC Chemotherapy (SWOG S9313)

      Authors
      S Stecklein;W Barlow;L Pusztai;TBA Myriad;TBA Almac;S Badve;Y Gokmen-Polar;P Porter;H Linden;D Tripathy;G Hortobagyi;A Godwin;A Thompson;D Hayes;P Sharma
      Journal / Conference
      San Antonio Breast Cancer Symposium (December 8-12, 2020, virtual), oral slide presentation
      Year
      2020
      Research Committee(s)
      Breast
      Study Number(s)
      SWOG-9313

      First results from a phase III randomized clinical trial of standard adjuvant endocrine therapy +/- chemotherapy in patients (pts) with 1-3 positive nodes, hormone receptor-positive (HR+) and HER2-negative breast cancer with recurrence score (RS) of 25 or less: SWOG S1007

      Authors
      K Kalinsky;W Barlow;F Meric-Bernstam;J Gralow;K Albain;D Hayes;N Lin;E Perez;L Goldstein;S Chia;S Dhesy-Thind;P Rastogi;E Alba;S Delaloge;M Martin;M Gil Gil;C Arce-Salinas;E Brain;I Park;J-Y Pierga;A Lluch Hernandez;M Ramos Vazquez;M Ruiz Borrego;KH Jung;J-M Ferrero;A Schott;S Shak;P Sharma;DL Lew;J Miao;D Tripathy;G Hortobagyi;L Pusztai
      Journal / Conference
      San Antonio Breast Cancer Symposium (December 8-12, 2020, virtual), oral presentation, abst. GS3-00
      Year
      2020
      Research Committee(s)
      Breast
      Study Number(s)
      S1007

      Predictors of pain reduction in trials of interventions for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS)

      Authors
      NL Henry;J Unger;C Till;K Crew;M Fisch;D Hershman
      Journal / Conference
      San Antonio Breast Cancer Symposium (December 8-12, 2020, virtual), Spotlight Poster-Discussion Session, abst # PD12-03
      Year
      2020
      Research Committee(s)
      Breast and Symptom Management and Survivorship
      Study Number(s)
      S0927, S1200, S1202

      Characteristics and Prognostic Effects of IDH Mutations across the Age Spectrum in AML: A Collaborative Analysis from COG, SWOG, and ECOG

      Authors
      S Zarnegar-Lumley;T Alonzo;M Othus;Z Sun;R Ries;Y Wang;A Leonti;M Kutney;D Stirewalt;J Radich;F Appelbaum;E Pogosova-Agadjanyan;K O'Dwyer;H Erba;O Abdel-Wahab;M Tallman;M Litzow;E Atallah;S Luger;R Levine;T Cooper;A Gamis;R Aplenc;A Kolb;S Meshinchi;K Tarlock
      Journal / Conference
      American Society of Hematology (December 5-8, 2020, San Diego, CA), oral, abst #388
      Year
      2020
      Research Committee(s)
      Leukemia
      Study Number(s)
      S0106

      E2112: Randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer. A trial of the ECOG-ACRIN Cancer Research Group

      Authors
      R Connolly;F Zhao;K Miller;M Lee;R Piekarz;K Smith;U Brown-Glaberman;J Winn;A Lyss;A Onitilo;M Burkard;G Budd;E Levine;M Royce;P Kaufman;A Thomas;J Trepel;A Wolff;J Sparano
      Journal / Conference
      San Antonio Breast Cancer Symposium (December 8-12, 2020, virtual), oral slide presentation, abst. GS402
      Year
      2020
      Research Committee(s)
      Breast
      Study Number(s)
      CTSU/E2112

      Incidence and Prognostic Impact of Crh in Acute Myeloid Leukemia

      Authors
      M Othus;G Garcia-Manero;F Appelbaum;H Erba;E Estey
      Journal / Conference
      American Society of Hematology (December 5-8, 2020, virtual), poster presentation
      Year
      2020
      Research Committee(s)
      Leukemia
      Study Number(s)
      S1203

      Prognostication for Advanced Stage Hodgkin Lymphoma (HL) in the Modern Era: A Project from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

      Authors
      A Rodday;S Parsons;C Scharman;R Advani;M Federico;J Friedberg;A Gallamini;D Hodgson;P Hoskin;M Hutchings;P Johnson;K Kelly;J Radford;P Luigi;J Cerhan;J Raemaekers;Holistic Consortium
      Journal / Conference
      American Society of Hematology (December 5-8, 2020, virtual), poster presentation
      Year
      2020
      Research Committee(s)
      Lymphoma
      Study Number(s)
      S0816